BioPharma Clinical Trials

AWS and Accenture Aid Merck in Cloud-Powered Drug Discovery and Clinical Trial Acceleration

At AWS re:Invent, Amazon Web Services, Inc. (AWS), an, Inc. company (NASDAQ: AMZN), today announced it is working with Accenture (NYSE: ACN...

 November 30, 2023 | News

Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort

Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled a...

 November 30, 2023 | News

AbbVie Provides FDA and EMA Updates on Epcoritamab for Lymphoma Treatment

Updates are supported by data from the Phase 1/2 EPCORE™ NHL-1 clinical trial AbbVie  announced updates from the U...

 November 29, 2023 | News

Everest Medicines Gets NMPA Approval for Nefecon® in China for IgA Nephropathy

--Nefecon® is the first approved medicine with an IgAN indication in China-- --The approval marks a new era of IgAN treatment for Chinese patient...

 November 27, 2023 | News

DxVx Plans License-In of OVM-200, Launches Clinical Trials in Asia

Final stage in licensing OVM-200 from Oxford Vacmedix in the UK- DxVx plans to proceed its own clinical trials in Asia, including Korea and Chi...

 November 27, 2023 | News

Simcere and Connect ink exclusive deal for autoimmune drug Rademikibart.

Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...

 November 24, 2023 | News

BeiGene and Ensem Therapeutics Partner to Advance CDK2 Inhibitor

“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...

 November 23, 2023 | News

Senhwa Biosciences Granted FDA IND for Phase II Study of Silmitasertib in Viral Community-Acquired Pneumonia (CAP)

The trial is a phase II multi-center, randomized-controlled interventional prospective study, and the purpose of this trial is to investigate whether ...

 November 22, 2023 | News

Micron Biomedical Secures $23.6M to Advance Needle-Free Vaccine Production for Measles Eradication

Micron has received this grant from the Bill & Melinda Gates Foundation to fund mass production of needle-free vaccines utilizing Micron technology t...

 November 20, 2023 | News

Clinical trial expands evidence base for the Wobenzym® brand

A recent clinic trial is expanding the evidence base for the Wobenzym® brand. The results are published in Therapeutic Advances in Musculoske...

 November 19, 2023 | News

ACROBiosystems Introduces GM-Grade DLL4 Protein for Faster Stem Cell Manufacturing

The availability of DLL4 manufactured under GMP conditions represents a significant milestone for enterprises engaged in developing or manufacturing stem-c...

 November 17, 2023 | News

TB Alliance Initiates Phase 2 Trial for Next-Gen TB Drug in Five Countries

Early results presented at the Union World Conference on Lung Health suggest promise of new compound to fight tuberculosis that will be tested as part of P...

 November 17, 2023 | News

Telix, an Australian Company, Announces Planned Acquisition of QSAM Biosciences and its Lead Therapy Candidate, CycloSam

CycloSam® is highly synergistic with Telix's existing therapeutic development activity in both prostate cancer and sarcoma. The proposed acquisiti...

 November 14, 2023 | News

George Clinical and Medidata Partner in Australia to Boost Operational Efficiency in Clinical Trials

Medidata, a Dassault Systèmes company, announced that George Clinical, a leading global clinical research organization, is leveraging Medidata's clo...

 November 14, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in